anakinra 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
interleukin receptor antagonists and interleukin antagonists 5017 143090-92-0

Description:

MoleculeDescription

Synonyms:

  • anakinra
  • kineret
A ligand that binds to but fails to activate the INTERLEUKIN 1 RECEPTOR. It plays an inhibitory role in the regulation of INFLAMMATION and FEVER. Several isoforms of the protein exist due to multiple ALTERNATIVE SPLICING of its mRNA. As IL-1 levels are elevated in patients with COVID-19, anakinra is currently being investigated for its potential to combat cytokine release syndrome (CRS) in patients with severely ill COVID-19.
  • Molecular weight: 17257.66
  • Formula: C759H1186N208O232S10
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 7115.02
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
0.10 g P

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
Nov. 14, 2001 FDA BIOVITRUM AB
March 8, 2002 EMA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug ineffective 781.29 17.09 1868 40368 1382430 89203781
Haemophagocytic lymphohistiocytosis 727.34 17.09 273 41963 15186 90571025
Red blood cell sedimentation rate abnormal 706.38 17.09 303 41933 23901 90562310
Polyarthritis 592.95 17.09 247 41989 18103 90568108
Adrenal insufficiency 509.47 17.09 258 41978 29663 90556548
Joint destruction 501.64 17.09 200 42036 13087 90573124
Off label use 444.42 17.09 1317 40919 1100935 89485276
Loss of consciousness 420.77 17.09 416 41820 139822 90446389
Body height below normal 337.75 17.09 95 42141 2073 90584138
Bone density decreased 332.01 17.09 162 42074 17183 90569028
Deformity 317.96 17.09 141 42095 12029 90574182
Human antichimeric antibody positive 313.78 17.09 86 42150 1700 90584511
Oral mucosal exfoliation 295.58 17.09 82 42154 1698 90584513
Mobility decreased 287.23 17.09 459 41777 250275 90335936
Wheelchair user 275.90 17.09 112 42124 7673 90578538
Immunodeficiency 272.69 17.09 197 42039 43037 90543174
Drug tolerance 268.94 17.09 142 42094 17774 90568437
Therapeutic product effect decreased 267.11 17.09 470 41766 277101 90309110
Musculoskeletal disorder 259.04 17.09 148 42088 21621 90564590
Nodule 256.32 17.09 158 42078 26528 90559683
Septic shock 245.41 17.09 246 41990 83914 90502297
Gastroenteritis viral 235.25 17.09 157 42079 30198 90556013
Herpes zoster 233.56 17.09 253 41983 94391 90491820
Synovitis 230.88 17.09 488 41748 329264 90256947
Drug intolerance 228.55 17.09 585 41651 447006 90139205
Ill-defined disorder 226.17 17.09 349 41887 184542 90401669
Ankle arthroplasty 225.38 17.09 74 42162 2757 90583454
Soft tissue disorder 224.62 17.09 82 42154 4208 90582003
Arthritis 220.49 17.09 327 41909 166988 90419223
Therapy non-responder 218.41 17.09 293 41943 136411 90449800
Cutaneous vasculitis 216.17 17.09 92 42144 7101 90579110
Liver function test abnormal 213.04 17.09 182 42054 50663 90535548
Contraindicated product administered 211.70 17.09 463 41773 319676 90266535
Rheumatoid factor positive 200.15 17.09 317 41919 171333 90414878
Condition aggravated 197.19 17.09 667 41569 594878 89991333
Hypocalcaemia 174.11 17.09 150 42086 42218 90543993
Fine motor skill dysfunction 168.46 17.09 71 42165 5348 90580863
Therapeutic product effect incomplete 165.57 17.09 312 41924 193584 90392627
Obesity 163.68 17.09 223 42013 105284 90480927
Antibody test positive 163.45 17.09 59 42177 2930 90583281
Treatment failure 161.90 17.09 404 41832 303524 90282687
Short stature 158.14 17.09 45 42191 1025 90585186
Drug specific antibody 150.28 17.09 53 42183 2459 90583752
Psoriasis 148.12 17.09 255 41981 147499 90438712
Arthropathy 147.26 17.09 439 41797 365803 90220408
Adenovirus infection 135.19 17.09 58 42178 4564 90581647
Pneumonia viral 132.59 17.09 70 42166 8753 90577458
Spinal stenosis 132.29 17.09 89 42147 17335 90568876
Limb discomfort 131.13 17.09 122 42114 37938 90548273
Hepatosplenic T-cell lymphoma 129.79 17.09 35 42201 649 90585562
Joint swelling 129.52 17.09 520 41716 502780 90083431
Drug hypersensitivity 129.02 17.09 491 41745 463118 90123093
Infection 128.82 17.09 416 41820 361678 90224533
Fall 128.70 17.09 33 42203 481777 90104434
Foot operation 128.46 17.09 69 42167 8932 90577279
Body tinea 127.28 17.09 45 42191 2103 90584108
Drug ineffective for unapproved indication 127.03 17.09 156 42080 66488 90519723
Foot deformity 125.78 17.09 147 42089 59504 90526707
Secretion discharge 122.61 17.09 82 42154 15814 90570397
Red blood cell sedimentation rate increased 119.72 17.09 169 42067 82426 90503785
Ankle operation 118.51 17.09 39 42197 1463 90584748
Growth failure 118.37 17.09 29 42207 360 90585851
Vasculitic rash 112.81 17.09 37 42199 1373 90584838
Quality of life decreased 110.61 17.09 69 42167 11820 90574391
Loss of personal independence in daily activities 108.72 17.09 213 42023 135892 90450319
Dyspnoea 108.32 17.09 152 42084 880803 89705408
Asthenia 108.20 17.09 57 42179 533694 90052517
Impaired quality of life 107.58 17.09 88 42148 23056 90563155
Inhibitory drug interaction 106.93 17.09 44 42192 3119 90583092
Immune effector cell-associated neurotoxicity syndrome 104.76 17.09 52 42184 5716 90580495
Serum ferritin increased 103.71 17.09 56 42180 7325 90578886
Rheumatoid arthritis 103.22 17.09 387 41849 362227 90223984
Epidural lipomatosis 103.15 17.09 24 42212 235 90585976
Pleural effusion 102.78 17.09 186 42050 111805 90474406
Headache 101.01 17.09 154 42082 862592 89723619
Infection susceptibility increased 100.97 17.09 45 42191 3881 90582330
Smear cervix abnormal 100.45 17.09 42 42194 3100 90583111
Confusional state 100.16 17.09 28 42208 386177 90200034
Juvenile idiopathic arthritis 97.23 17.09 44 42192 3933 90582278
Hypokalaemia 93.76 17.09 196 42040 130920 90455291
Pulmonary fibrosis 92.92 17.09 174 42062 107329 90478882
Hepatotoxicity 88.46 17.09 108 42128 45734 90540477
Arthrodesis 85.48 17.09 37 42199 2975 90583236
Serum amyloid A protein increased 83.22 17.09 25 42211 692 90585519
Infiltration anaesthesia 82.41 17.09 19 42217 178 90586033
Growth retardation 82.04 17.09 31 42205 1752 90584459
Constipation 79.16 17.09 17 42219 280378 90305833
Hepatitis 78.71 17.09 128 42108 70611 90515600
Clubbing 78.29 17.09 22 42214 478 90585733
Sinusitis 73.44 17.09 34 42202 343054 90243157
Glucose tolerance impaired 73.41 17.09 46 42190 7939 90578272
Anxiety 72.26 17.09 27 42209 309745 90276466
Weight decreased 72.00 17.09 44 42192 379866 90206345
Arthralgia 71.53 17.09 612 41624 777910 89808301
Varicella zoster virus infection 70.55 17.09 35 42201 3842 90582369
Hypoaesthesia 67.46 17.09 31 42205 314179 90272032
Leukopenia 66.74 17.09 146 42090 100564 90485647
Complications of bone marrow transplant 65.98 17.09 19 42217 452 90585759
Decreased appetite 65.45 17.09 48 42188 376492 90209719
Bone density increased 65.33 17.09 22 42214 887 90585324
Cushingoid 64.66 17.09 47 42189 10348 90575863
Hypertensive cardiomyopathy 64.53 17.09 17 42219 287 90585924
Sensitivity to weather change 64.02 17.09 44 42192 8870 90577341
Muscle spasms 63.90 17.09 19 42217 251864 90334347
Discomfort 63.83 17.09 24 42212 274311 90311900
Lower respiratory tract infection 63.42 17.09 19 42217 250640 90335571
Death 62.99 17.09 72 42164 456479 90129732
Shoulder arthroplasty 62.44 17.09 33 42203 4133 90582078
Epstein-Barr viraemia 62.04 17.09 24 42212 1446 90584765
Asthma 61.92 17.09 18 42218 242142 90344069
C-reactive protein abnormal 60.08 17.09 162 42074 127267 90458944
Viraemia 59.09 17.09 24 42212 1645 90584566
Interstitial lung disease 59.07 17.09 118 42118 76287 90509924
General physical health deterioration 58.25 17.09 48 42188 355067 90231144
Blister 58.18 17.09 23 42213 254975 90331236
Cough 57.93 17.09 52 42184 368910 90217301
Drug reaction with eosinophilia and systemic symptoms 56.83 17.09 84 42152 42674 90543537
Folliculitis 54.47 17.09 14 42222 204339 90381872
Joint effusion 54.44 17.09 56 42180 19654 90566557
Helicobacter infection 54.20 17.09 19 42217 226831 90359380
Poor quality sleep 53.95 17.09 62 42174 24631 90561580
Pneumonia 53.72 17.09 138 42098 637921 89948290
Injection site reaction 52.71 17.09 126 42110 91954 90494257
Cytokine release syndrome 52.50 17.09 65 42171 27908 90558303
Steroid dependence 52.00 17.09 24 42212 2245 90583966
Paraesthesia 51.73 17.09 26 42210 250300 90335911
Somnolence 50.84 17.09 17 42219 209067 90377144
Oral herpes 50.64 17.09 70 42166 33454 90552757
Dehydration 50.54 17.09 14 42222 194433 90391778
Duodenal ulcer perforation 50.41 17.09 20 42216 221268 90364943
Febrile neutropenia 50.36 17.09 7 42229 158342 90427869
Purpura 50.17 17.09 47 42189 14731 90571480
Fatigue 50.17 17.09 324 41912 1153699 89432512
Pain in extremity 50.12 17.09 83 42153 450446 90135765
Oedema peripheral 50.06 17.09 29 42207 257886 90328325
Graft versus host disease in gastrointestinal tract 49.96 17.09 29 42207 4359 90581852
Anti-neutrophil cytoplasmic antibody positive vasculitis 49.78 17.09 28 42208 3965 90582246
Drug interaction 49.65 17.09 34 42202 276419 90309792
Epstein-Barr virus infection 49.47 17.09 40 42196 10304 90575907
Skin disorder 48.62 17.09 72 42164 36634 90549577
Irritable bowel syndrome 48.49 17.09 18 42218 207430 90378781
Impaired work ability 48.20 17.09 52 42184 19274 90566937
C-reactive protein increased 47.73 17.09 189 42047 181200 90405011
Hyponatraemia 47.30 17.09 4 42232 133534 90452677
Cytopenia 47.16 17.09 49 42187 17400 90568811
Clear cell renal cell carcinoma 46.78 17.09 20 42216 1560 90584651
Diaphragm muscle weakness 46.20 17.09 9 42227 33 90586178
Neuropathy peripheral 46.14 17.09 5 42231 136965 90449246
Palpitations 46.04 17.09 5 42231 136723 90449488
Wound 46.01 17.09 44 42192 302936 90283275
Wheezing 45.88 17.09 27 42209 238053 90348158
Cellulitis staphylococcal 45.58 17.09 17 42219 926 90585285
Infusion related reaction 45.23 17.09 78 42158 416702 90169509
Pruritus 44.88 17.09 118 42118 541407 90044804
Blood lactate dehydrogenase decreased 44.32 17.09 12 42224 226 90585985
Chest discomfort 44.28 17.09 6 42230 138359 90447852
Tremor 43.79 17.09 9 42227 153164 90433047
Overdose 43.60 17.09 10 42226 157699 90428512
Actinomycotic sepsis 43.27 17.09 12 42224 248 90585963
Hyperferritinaemia 43.06 17.09 13 42223 366 90585845
Dry mouth 42.97 17.09 16 42220 184043 90402168
Herpes zoster infection neurological 42.34 17.09 14 42222 533 90585678
Muscular weakness 41.90 17.09 22 42214 206644 90379567
Muscle injury 41.84 17.09 15 42221 176639 90409572
Hair follicle tumour benign 41.81 17.09 13 42223 405 90585806
Human anti-human antibody test 41.50 17.09 13 42223 415 90585796
Haemoglobin decreased 41.46 17.09 12 42224 161944 90424267
Hepatosplenomegaly 39.97 17.09 22 42214 2987 90583224
Joint arthroplasty 39.64 17.09 23 42213 3454 90582757
Nasopharyngitis 39.08 17.09 82 42154 407022 90179189
Memory impairment 38.52 17.09 22 42214 197222 90388989
Renal mass 37.92 17.09 20 42216 2495 90583716
Osteomyelitis 37.43 17.09 55 42181 27791 90558420
Adrenal suppression 37.41 17.09 15 42221 994 90585217
Autoinflammatory disease 37.34 17.09 11 42225 284 90585927
Injury 37.15 17.09 23 42213 197326 90388885
Endodontic procedure 37.02 17.09 22 42214 3453 90582758
Pericarditis 36.79 17.09 43 42193 270108 90316103
Parvovirus infection 35.56 17.09 12 42224 487 90585724
Myocardial infarction 35.36 17.09 4 42232 105968 90480243
Scar excision 34.99 17.09 8 42228 72 90586139
Graft versus host disease in skin 34.93 17.09 22 42214 3831 90582380
Chondrocalcinosis 33.95 17.09 16 42220 1569 90584642
Sleep disorder due to general medical condition, insomnia type 33.94 17.09 9 42227 128685 90457526
White blood cell count decreased 33.56 17.09 18 42218 167091 90419120
Abdominal discomfort 33.06 17.09 113 42123 477215 90108996
Acute graft versus host disease in skin 33.03 17.09 23 42213 4733 90581478
Stomatitis 33.01 17.09 48 42188 274650 90311561
Toxicity to various agents 32.95 17.09 52 42184 287794 90298417
Alveolar proteinosis 32.40 17.09 13 42223 863 90585348
Atrial fibrillation 32.23 17.09 11 42225 133600 90452611
Gastrooesophageal reflux disease 31.84 17.09 19 42217 166318 90419893
Hypertransaminasaemia 31.69 17.09 38 42198 15787 90570424
Fibromyalgia 31.68 17.09 184 42052 206085 90380126
Balance disorder 31.56 17.09 4 42232 97076 90489135
Bronchitis 31.40 17.09 16 42220 152911 90433300
Interleukin level increased 31.23 17.09 12 42224 710 90585501
Hepatic enzyme increased 31.09 17.09 77 42159 360659 90225552
Therapeutic response decreased 30.81 17.09 102 42134 89627 90496584
Focal nodular hyperplasia 30.45 17.09 12 42224 760 90585451
Hyperlipidaemia 30.42 17.09 45 42191 22871 90563340
Pneumonia lipoid 30.32 17.09 8 42228 136 90586075
Type 2 diabetes mellitus 30.28 17.09 30 42206 203214 90382997
Cerebrovascular accident 30.09 17.09 10 42226 123523 90462688
Demyelination 29.79 17.09 27 42209 8113 90578098
Human herpesvirus 6 infection 29.62 17.09 19 42217 3413 90582798
Skin fissures 29.27 17.09 42 42194 20767 90565444
Gait disturbance 28.93 17.09 48 42188 260448 90325763
Product dose omission issue 28.61 17.09 58 42178 291629 90294582
Intentional product use issue 28.60 17.09 186 42050 216706 90369505
Encephalitis viral 28.42 17.09 15 42221 1874 90584337
Chills 28.33 17.09 13 42223 131968 90454243
Pyrexia 28.18 17.09 448 41788 660037 89926174
Skin graft infection 27.99 17.09 7 42229 95 90586116
Fluid retention 27.76 17.09 4 42232 88087 90498124
Dry skin 27.75 17.09 4 42232 88069 90498142
Drug abuse 27.75 17.09 3 42233 82344 90503867
Inappropriate schedule of product administration 27.49 17.09 18 42218 149915 90436296
Cytomegalovirus viraemia 27.44 17.09 25 42211 7561 90578650
Toothache 27.16 17.09 42 42194 22188 90564023
Laryngeal stenosis 27.10 17.09 13 42223 1326 90584885
Myalgia 27.07 17.09 25 42211 175100 90411111
Alopecia 26.84 17.09 129 42107 494942 90091269
Lip dry 26.73 17.09 7 42229 100948 90485263
Muckle-Wells syndrome 26.69 17.09 4 42232 0 90586211
Gait inability 26.29 17.09 18 42218 146438 90439773
Hyperplasia 26.10 17.09 12 42224 1112 90585099
Joint injury 25.90 17.09 51 42185 32613 90553598
Platelet count decreased 25.72 17.09 16 42220 136953 90449258
Drug specific antibody present 25.69 17.09 21 42215 5493 90580718
Bacterial sepsis 25.49 17.09 20 42216 4935 90581276
Joint range of motion decreased 25.26 17.09 16 42220 135627 90450584
Spondyloarthropathy 25.13 17.09 12 42224 1212 90584999
Deep vein thrombosis 24.94 17.09 6 42230 91614 90494597
Borrelia infection 24.44 17.09 8 42228 295 90585916
Upper respiratory tract infection 24.08 17.09 15 42221 128303 90457908
Lymphodepletion 23.94 17.09 5 42231 28 90586183
Serum ferritin decreased 23.88 17.09 15 42221 2599 90583612
Thrombosis 23.85 17.09 3 42233 73248 90512963
Medical device site discomfort 23.84 17.09 8 42228 319 90585892
Soft tissue swelling 23.78 17.09 12 42224 1366 90584845
Renal failure 23.65 17.09 16 42220 130991 90455220
Nasal congestion 23.63 17.09 5 42231 83409 90502802
Rhinorrhoea 23.62 17.09 6 42230 88310 90497901
Exfoliative rash 23.50 17.09 16 42220 3176 90583035
Neck pain 23.24 17.09 110 42126 113853 90472358
Tumour necrosis factor receptor-associated periodic syndrome 23.19 17.09 6 42230 94 90586117
Breast ulceration 22.99 17.09 7 42229 203 90586008
Diffuse large B-cell lymphoma 22.86 17.09 24 42212 8621 90577590
Back disorder 22.77 17.09 42 42194 25589 90560622
Symptom recurrence 22.60 17.09 17 42219 3942 90582269
Guillain-Barre syndrome 22.41 17.09 18 42218 4594 90581617
Cognitive disorder 22.22 17.09 3 42233 69404 90516807
Vision blurred 21.96 17.09 12 42224 110281 90475930
Fasciitis 21.95 17.09 9 42227 632 90585579
Incorrect dose administered 21.82 17.09 5 42231 78925 90507286
Product use issue 21.61 17.09 242 41994 329677 90256534
Hyperhidrosis 21.61 17.09 19 42217 136286 90449925
Inflammatory marker increased 21.60 17.09 24 42212 9190 90577021
Post transplant lymphoproliferative disorder 21.50 17.09 21 42215 6928 90579283
Urinary tract infection 21.37 17.09 72 42164 305560 90280651
Bursitis 21.30 17.09 18 42218 131636 90454575
Migraine 21.21 17.09 35 42201 190357 90395854
Obliterative bronchiolitis 21.08 17.09 14 42222 2667 90583544
Blood glucose increased 21.04 17.09 9 42227 95237 90490974
Embolism 21.04 17.09 24 42212 9457 90576754
Ankylosing spondylitis 20.70 17.09 28 42208 13105 90573106
Dyspepsia 20.64 17.09 38 42198 198122 90388089
Chest pain 20.56 17.09 78 42158 319567 90266644
Hodgkin's disease 20.51 17.09 9 42227 748 90585463
Lower limb fracture 20.50 17.09 7 42229 85006 90501205
Gastrointestinal disorder 20.42 17.09 57 42179 256630 90329581
Bradycardia 20.05 17.09 7 42229 83840 90502371
Impaired gastric emptying 19.72 17.09 27 42209 12782 90573429
Road traffic accident 19.62 17.09 13 42223 107613 90478598
Oxygen saturation decreased 19.57 17.09 13 42223 107470 90478741
Liver disorder 19.11 17.09 17 42219 121252 90464959
Blau syndrome 19.06 17.09 4 42232 23 90586188
Agitation 19.05 17.09 4 42232 67094 90519117
Vitiligo 19.01 17.09 12 42224 2098 90584113
Mouth ulceration 19.00 17.09 51 42185 39923 90546288
Amyloidosis 18.97 17.09 10 42226 1246 90584965
Wrong technique in product usage process 18.88 17.09 5 42231 71566 90514645
Epistaxis 18.87 17.09 8 42228 85117 90501094
Respiratory acidosis 18.78 17.09 21 42215 8098 90578113
BK virus infection 18.62 17.09 16 42220 4482 90581729
Haematochezia 18.62 17.09 5 42231 70908 90515303
Autoimmune thyroiditis 18.59 17.09 18 42218 5875 90580336
Suicide attempt 18.54 17.09 6 42230 75393 90510818
Periodontal inflammation 18.26 17.09 4 42232 29 90586182
Swollen joint count increased 18.24 17.09 15 42221 111191 90475020
Erythema 18.16 17.09 51 42185 229195 90357016
Hypofibrinogenaemia 18.15 17.09 10 42226 1360 90584851
Seizure 18.00 17.09 27 42209 152602 90433609
Rectal haemorrhage 17.99 17.09 8 42228 82736 90503475
Secondary adrenocortical insufficiency 17.97 17.09 12 42224 2306 90583905
Blood creatine phosphokinase decreased 17.90 17.09 8 42228 694 90585517
Facet joint syndrome 17.78 17.09 12 42224 98377 90487834
Cytomegalovirus infection reactivation 17.74 17.09 20 42216 7780 90578431
Heart rate increased 17.59 17.09 16 42220 112886 90473325
Haematological malignancy 17.56 17.09 7 42229 457 90585754
Swelling face 17.48 17.09 8 42228 81344 90504867
Unwanted pregnancy 17.36 17.09 5 42231 119 90586092
Amnesia 17.35 17.09 15 42221 108490 90477721
Mucosal inflammation 17.29 17.09 3 42233 57622 90528589

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Apparent death 978.98 29.56 231 14061 3477 42603566
Off label use 777.96 29.56 1000 13292 637335 41969708
Diverticulitis 649.42 29.56 255 14037 22518 42584525
Drug ineffective 425.70 29.56 753 13539 629444 41977599
Joint swelling 402.41 29.56 262 14030 67760 42539283
Deep vein thrombosis 373.02 29.56 262 14030 76695 42530348
Pulmonary thrombosis 368.49 29.56 129 14163 8219 42598824
Red blood cell sedimentation rate increased 357.74 29.56 132 14160 9792 42597251
Terminal state 293.65 29.56 93 14199 4330 42602713
Haemophagocytic lymphohistiocytosis 277.20 29.56 131 14161 18091 42588952
Renal failure 273.48 29.56 286 14006 143440 42463603
Pulmonary embolism 254.68 29.56 253 14039 119359 42487684
C-reactive protein abnormal 243.70 29.56 98 14194 9163 42597880
Acne cystic 178.50 29.56 41 14251 541 42606502
Contraindicated product administered 175.69 29.56 108 14184 25164 42581879
Drug ineffective for unapproved indication 175.54 29.56 136 14156 46027 42561016
Drug specific antibody present 173.23 29.56 61 14231 3945 42603098
Intestinal sepsis 152.93 29.56 38 14254 713 42606330
Pain 149.48 29.56 282 14010 244566 42362477
Joint arthroplasty 147.78 29.56 39 14253 938 42606105
Photosensitivity reaction 147.44 29.56 76 14216 12626 42594417
Thrombosis 134.67 29.56 139 14153 68372 42538671
Interleukin level increased 131.33 29.56 35 14257 875 42606168
C-reactive protein increased 121.38 29.56 127 14165 63433 42543610
Sepsis 112.17 29.56 222 14070 199112 42407931
Drug reaction with eosinophilia and systemic symptoms 94.82 29.56 92 14200 41983 42565060
Drug intolerance 94.01 29.56 125 14167 80299 42526744
Cytokine release syndrome 92.26 29.56 93 14199 44434 42562609
Monocyte chemotactic protein-1 increased 92.17 29.56 22 14270 346 42606697
Alpha tumour necrosis factor increased 91.88 29.56 22 14270 351 42606692
Herpes zoster 91.37 29.56 87 14205 38790 42568253
Gait inability 90.49 29.56 69 14223 22764 42584279
Drug use disorder 89.69 29.56 51 14241 10282 42596761
Treatment failure 88.49 29.56 107 14185 62517 42544526
Immune effector cell-associated neurotoxicity syndrome 82.93 29.56 47 14245 9414 42597629
Dyspnoea 81.24 29.56 24 14268 442597 42164446
Arthropathy 80.74 29.56 72 14220 29525 42577518
Stent placement 79.79 29.56 38 14254 5322 42601721
Intentional product use issue 78.38 29.56 108 14184 71725 42535318
Stomatitis 72.73 29.56 87 14205 50242 42556801
Urticaria 71.47 29.56 105 14187 73931 42533112
Diarrhoea 71.11 29.56 33 14259 460816 42146227
Injection site reaction 70.09 29.56 51 14241 15670 42591373
Knee arthroplasty 64.75 29.56 39 14253 8742 42598301
Interstitial lung disease 64.09 29.56 103 14189 78359 42528684
Drug hypersensitivity 63.50 29.56 117 14175 99272 42507771
Propionibacterium infection 62.78 29.56 15 14277 237 42606806
Meningitis viral 60.16 29.56 20 14272 1085 42605958
Systemic candida 56.49 29.56 30 14262 5289 42601754
Spinal cord injury cervical 55.39 29.56 14 14278 282 42606761
Drug interaction 53.63 29.56 12 14280 266987 42340056
Fatigue 52.11 29.56 42 14250 435599 42171444
Condition aggravated 50.88 29.56 197 14095 260557 42346486
Serum ferritin increased 50.50 29.56 31 14261 7188 42599855
Rebound effect 49.87 29.56 31 14261 7348 42599695
Immobilisation syndrome 48.80 29.56 14 14278 462 42606581
Dizziness 46.57 29.56 13 14279 249241 42357802
Multiple-drug resistance 45.08 29.56 29 14263 7293 42599750
Cytomegalovirus hepatitis 42.91 29.56 13 14279 520 42606523
Serum amyloid A protein increased 41.81 29.56 11 14281 261 42606782
Drug dependence 41.52 29.56 50 14242 29044 42577999
Therapeutic product effect decreased 41.37 29.56 58 14234 39092 42567951
Central nervous system lymphoma 41.11 29.56 16 14276 1369 42605674
Disseminated mucormycosis 41.04 29.56 16 14276 1375 42605668
Oral fungal infection 40.17 29.56 17 14275 1804 42605239
Testicular seminoma (pure) 39.68 29.56 10 14282 199 42606844
Feeling abnormal 39.41 29.56 78 14214 69708 42537335
Septic shock 38.63 29.56 91 14201 91581 42515462
Streptococcal infection 37.05 29.56 24 14268 6108 42600935
Product use in unapproved indication 36.43 29.56 140 14152 184316 42422727
Myocardial infarction 35.86 29.56 107 14185 123902 42483141
Rheumatoid arthritis 35.01 29.56 56 14236 42384 42564659
Post transplant lymphoproliferative disorder 34.89 29.56 27 14265 9093 42597950
Decreased appetite 34.36 29.56 11 14281 193126 42413917
Hyperferritinaemia 33.17 29.56 11 14281 592 42606451
Opportunistic infection 32.28 29.56 15 14277 1986 42605057
Glucose tolerance impaired 32.18 29.56 19 14273 4105 42602938
Varicella 31.83 29.56 15 14277 2050 42604993
Fall 31.38 29.56 20 14272 234500 42372543
Somnolence 31.14 29.56 5 14287 141100 42465943
Alveolar proteinosis 31.11 29.56 11 14281 719 42606324
Fungal skin infection 30.36 29.56 17 14275 3324 42603719
Inflammatory marker increased 30.29 29.56 22 14270 6734 42600309
Multiple organ dysfunction syndrome 30.23 29.56 86 14206 96949 42510094
Cytomegalovirus infection reactivation 30.08 29.56 27 14265 11151 42595892
Cytopenia 29.89 29.56 33 14259 17464 42589579
Bradycardia foetal 29.78 29.56 9 14283 357 42606686

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Off label use 928.07 16.39 1942 43322 1498243 109045792
Drug ineffective 883.26 16.39 1919 43345 1518621 109025414
Haemophagocytic lymphohistiocytosis 676.37 16.39 306 44958 31253 110512782
Red blood cell sedimentation rate abnormal 636.41 16.39 272 44992 24237 110519798
Polyarthritis 471.05 16.39 204 45060 18759 110525276
Joint destruction 406.16 16.39 157 45107 10786 110533249
Drug intolerance 382.95 16.39 634 44630 405878 110138157
Apparent death 353.49 16.39 102 45162 2800 110541235
Contraindicated product administered 342.22 16.39 463 44801 247804 110296231
Adrenal insufficiency 328.90 16.39 209 45055 42181 110501854
Human antichimeric antibody positive 317.39 16.39 84 45180 1658 110542377
Red blood cell sedimentation rate increased 316.91 16.39 260 45004 78042 110465993
Oral mucosal exfoliation 308.18 16.39 81 45183 1555 110542480
Body height below normal 302.48 16.39 84 45180 2000 110542035
Therapeutic product effect decreased 275.27 16.39 414 44850 243902 110300133
Bone density decreased 267.86 16.39 131 45133 15911 110528124
Drug ineffective for unapproved indication 252.39 16.39 258 45006 102580 110441455
Synovitis 250.34 16.39 422 44842 273670 110270365
Wheelchair user 247.21 16.39 100 45164 7742 110536293
Treatment failure 246.81 16.39 422 44842 276812 110267223
Joint swelling 231.09 16.39 539 44725 442306 110101729
Pulmonary thrombosis 227.85 16.39 112 45152 13751 110530284
Herpes zoster 227.11 16.39 250 45014 108129 110435906
Arthropathy 224.16 16.39 413 44851 287109 110256926
Terminal state 219.91 16.39 84 45180 5583 110538452
Septic shock 217.14 16.39 294 44970 157234 110386801
Immunodeficiency 216.38 16.39 156 45108 38682 110505353
Rheumatoid factor positive 213.11 16.39 266 44998 131374 110412661
Condition aggravated 212.99 16.39 722 44542 734114 109809921
Drug tolerance 192.21 16.39 106 45158 16479 110527556
Gastroenteritis viral 186.81 16.39 131 45133 31095 110512940
Therapy non-responder 184.79 16.39 272 44992 157035 110387000
C-reactive protein abnormal 184.73 16.39 246 45018 129449 110414586
Rheumatoid arthritis 184.64 16.39 390 44874 299223 110244812
Cutaneous vasculitis 183.21 16.39 94 45170 12635 110531400
Nodule 181.61 16.39 131 45133 32500 110511535
Ankle arthroplasty 164.11 16.39 55 45209 2496 110541539
Deformity 163.74 16.39 81 45183 10079 110533956
Drug hypersensitivity 161.29 16.39 479 44785 453611 110090424
Immune effector cell-associated neurotoxicity syndrome 159.10 16.39 90 45174 14692 110529343
Dyspnoea 156.94 16.39 134 45130 1106738 109437297
Drug specific antibody 154.70 16.39 54 45210 2774 110541261
Musculoskeletal disorder 154.32 16.39 103 45161 22561 110521474
Fine motor skill dysfunction 154.14 16.39 67 45197 6207 110537828
Arthritis 147.50 16.39 254 45010 167332 110376703
Drug specific antibody present 147.19 16.39 71 45193 8363 110535672
Joint arthroplasty 139.29 16.39 53 45211 3484 110540551
Antibody test positive 138.36 16.39 51 45213 3069 110540966
Cytokine release syndrome 138.34 16.39 157 45107 70149 110473886
Fall 136.50 16.39 39 45225 603443 109940592
Short stature 135.93 16.39 39 45225 1048 110542987
Diverticulitis 134.37 16.39 136 45128 53386 110490649
Body tinea 129.74 16.39 44 45220 2071 110541964
Mobility decreased 126.86 16.39 292 44972 237130 110306905
C-reactive protein increased 121.96 16.39 273 44991 217646 110326389
Soft tissue disorder 121.70 16.39 48 45216 3476 110540559
Loss of consciousness 120.19 16.39 255 45009 196051 110347984
Obesity 117.50 16.39 185 45079 113166 110430869
Interleukin level increased 116.50 16.39 38 45226 1583 110542452
Spinal stenosis 116.43 16.39 81 45183 18975 110525060
Secretion discharge 112.02 16.39 81 45183 20163 110523872
Psoriasis 108.79 16.39 201 45063 139792 110404243
Foot deformity 108.77 16.39 116 45148 48364 110495671
Foot operation 108.13 16.39 55 45209 7258 110536777
Smear cervix abnormal 108.11 16.39 41 45223 2671 110541364
Ill-defined disorder 108.10 16.39 214 45050 156639 110387396
Intestinal sepsis 107.78 16.39 32 45232 972 110543063
Confusional state 104.62 16.39 31 45233 468649 110075386
Therapeutic product effect incomplete 104.20 16.39 261 45003 223544 110320491
Ankle operation 101.67 16.39 33 45231 1353 110542682
Serum amyloid A protein increased 101.02 16.39 30 45234 912 110543123
Infection susceptibility increased 98.46 16.39 44 45220 4354 110539681
Hypocalcaemia 97.67 16.39 127 45137 65239 110478796
Vasculitic rash 96.80 16.39 36 45228 2221 110541814
Liver function test abnormal 93.86 16.39 128 45136 68822 110475213
Interstitial lung disease 93.48 16.39 188 45076 139146 110404889
Anxiety 92.78 16.39 15 45249 345063 110198972
Juvenile idiopathic arthritis 91.22 16.39 46 45218 5961 110538074
Inhibitory drug interaction 90.44 16.39 43 45221 4904 110539131
Drug interaction 90.32 16.39 46 45218 500137 110043898
Pneumonia viral 88.97 16.39 56 45208 11101 110532934
Monocyte chemotactic protein-1 increased 87.80 16.39 22 45242 346 110543689
Infection 87.56 16.39 336 44928 361864 110182171
Constipation 86.80 16.39 20 45244 357766 110186269
Hepatosplenic T-cell lymphoma 86.34 16.39 27 45237 980 110543055
Alpha tumour necrosis factor increased 85.34 16.39 22 45242 390 110543645
Toxicity to various agents 84.10 16.39 46 45218 480509 110063526
Drug reaction with eosinophilia and systemic symptoms 83.69 16.39 133 45131 81962 110462073
Serum ferritin increased 83.45 16.39 55 45209 11792 110532243
Limb discomfort 81.65 16.39 92 45172 40762 110503273
Quality of life decreased 81.39 16.39 58 45206 14111 110529924
Impaired quality of life 80.35 16.39 79 45185 29938 110514097
Asthenia 76.64 16.39 102 45162 688897 109855138
Infiltration anaesthesia 76.15 16.39 17 45247 157 110543878
Hyponatraemia 72.75 16.39 4 45260 217649 110326386
Decreased appetite 71.71 16.39 54 45210 475792 110068243
Somnolence 69.46 16.39 18 45246 297431 110246604
Intentional product use issue 69.16 16.39 241 45023 247665 110296370
Loss of personal independence in daily activities 68.78 16.39 174 45090 149846 110394189
Glucose tolerance impaired 67.67 16.39 45 45219 9792 110534243
Bone density increased 66.18 16.39 22 45242 973 110543062
Oedema peripheral 65.92 16.39 26 45238 328634 110215401
Photosensitivity reaction 64.17 16.39 65 45199 25524 110518511
Joint effusion 63.51 16.39 59 45205 20846 110523189
Cough 62.64 16.39 58 45206 461583 110082452
Hepatitis 62.17 16.39 123 45141 89931 110454104
Complications of bone marrow transplant 62.14 16.39 19 45245 639 110543396
General physical health deterioration 61.87 16.39 50 45214 425245 110118790
Overdose 60.98 16.39 11 45253 233783 110310252
Muscle spasms 60.93 16.39 19 45245 278138 110265897
Hyperferritinaemia 60.47 16.39 21 45243 1062 110542973
Paraesthesia 60.37 16.39 19 45245 276502 110267533
Injection site reaction 58.31 16.39 119 45145 88951 110455084
Hypoaesthesia 58.04 16.39 28 45236 314195 110229840
Propionibacterium infection 57.41 16.39 15 45249 281 110543754
Pulmonary fibrosis 57.20 16.39 128 45136 101914 110442121
Arthrodesis 57.06 16.39 26 45238 2692 110541343
Asthma 56.82 16.39 16 45248 250275 110293760
Post transplant lymphoproliferative disorder 55.20 16.39 48 45216 15565 110528470
Pleural effusion 55.06 16.39 179 45085 177530 110366505
Dehydration 54.60 16.39 23 45241 279488 110264547
Fatigue 54.31 16.39 285 44979 1215673 109328362
Systemic candida 53.12 16.39 39 45225 9935 110534100
Palpitations 52.97 16.39 3 45261 159209 110384826
Diffuse large B-cell lymphoma 52.46 16.39 47 45217 15851 110528184
Weight decreased 52.28 16.39 69 45195 467988 110076047
Pneumonia 52.28 16.39 184 45080 876530 109667505
Cytopenia 52.13 16.39 63 45201 30053 110513982
Pruritus 50.65 16.39 101 45163 581459 109962576
Malignant neoplasm progression 50.63 16.39 6 45258 174561 110369474
Headache 50.10 16.39 189 45075 882188 109661847
Tremor 49.63 16.39 11 45253 202221 110341814
Lower respiratory tract infection 49.12 16.39 19 45245 243087 110300948
Poor quality sleep 49.04 16.39 59 45205 28018 110516017
Death 48.44 16.39 137 45127 698732 109845303
Chest discomfort 47.97 16.39 7 45257 173841 110370194
Epstein-Barr virus infection 47.72 16.39 48 45216 18690 110525345
Neuropathy peripheral 47.70 16.39 8 45256 179269 110364766
Steroid dependence 47.11 16.39 34 45230 8435 110535600
Varicella zoster virus infection 45.91 16.39 30 45234 6338 110537697
Skin disorder 45.77 16.39 71 45193 42842 110501193
Drug use disorder 45.48 16.39 46 45218 18028 110526007
Cushingoid 45.48 16.39 38 45226 11674 110532361
Anti-neutrophil cytoplasmic antibody positive vasculitis 45.23 16.39 28 45236 5389 110538646
Product use issue 44.59 16.39 248 45016 311447 110232588
Cerebrovascular accident 44.20 16.39 10 45254 181274 110362761
Knee arthroplasty 43.97 16.39 88 45176 64860 110479175
Human anti-human antibody test 43.69 16.39 13 45251 398 110543637
Rebound effect 43.46 16.39 41 45223 14765 110529270
Dry mouth 43.17 16.39 14 45250 199934 110344101
Alveolar proteinosis 43.01 16.39 18 45246 1518 110542517
Sinusitis 42.98 16.39 35 45229 296653 110247382
Growth retardation 42.84 16.39 21 45243 2561 110541474
Febrile neutropenia 42.70 16.39 40 45224 316727 110227308
Clubbing 42.61 16.39 15 45249 790 110543245
Stent placement 42.44 16.39 30 45234 7204 110536831
Hair follicle tumour benign 42.35 16.39 13 45251 443 110543592
Endodontic procedure 41.80 16.39 22 45242 3114 110540921
Thrombosis 41.67 16.39 118 45146 108544 110435491
Meningitis viral 41.27 16.39 20 45244 2379 110541656
Disseminated mucormycosis 40.67 16.39 19 45245 2083 110541952
Platelet count decreased 40.35 16.39 22 45242 230421 110313614
Oral herpes 40.32 16.39 61 45203 36019 110508016
Wheezing 39.66 16.39 28 45236 255202 110288833
Cytomegalovirus infection reactivation 39.59 16.39 43 45221 18290 110525745
Shoulder arthroplasty 38.91 16.39 22 45242 3585 110540450
Clear cell renal cell carcinoma 38.64 16.39 20 45244 2736 110541299
Cellulitis staphylococcal 37.81 16.39 16 45248 1387 110542648
Actinomycotic sepsis 37.65 16.39 10 45254 200 110543835
Impaired work ability 37.39 16.39 50 45214 26369 110517666
Adenovirus infection 37.26 16.39 33 45231 10961 110533074
Transplant failure 36.89 16.39 25 45239 5610 110538425
Discomfort 36.87 16.39 21 45243 214686 110329349
Arthralgia 36.61 16.39 483 44781 779149 109764886
Herpes zoster infection neurological 36.51 16.39 12 45252 512 110543523
Pain in extremity 36.35 16.39 92 45172 487026 110057009
Hyperkalaemia 36.25 16.39 6 45258 135790 110408245
Scar excision 36.22 16.39 8 45256 70 110543965
Multiple organ dysfunction syndrome 35.98 16.39 140 45124 151570 110392465
Autoinflammatory disease 35.98 16.39 11 45253 370 110543665
Sensitivity to weather change 35.79 16.39 31 45233 9997 110534038
Hyperhidrosis 35.63 16.39 16 45248 187282 110356753
Rhabdomyolysis 35.26 16.39 4 45260 120397 110423638
Growth failure 34.98 16.39 10 45254 265 110543770
Hepatotoxicity 34.93 16.39 79 45185 63321 110480714
Adrenal suppression 34.90 16.39 16 45248 1680 110542355
Epidural lipomatosis 34.86 16.39 17 45247 2050 110541985
Atrial fibrillation 34.63 16.39 26 45238 229616 110314419
Memory impairment 34.19 16.39 19 45245 196925 110347110
Folliculitis 34.03 16.39 13 45251 167640 110376395
Blister 33.96 16.39 26 45238 227350 110316685
Balance disorder 33.81 16.39 4 45260 116556 110427479
Cytomegalovirus hepatitis 33.61 16.39 13 45251 893 110543142
Electrocardiogram QT prolonged 33.52 16.39 3 45261 108957 110435078
Renal mass 33.46 16.39 20 45244 3615 110540420
Inappropriate schedule of product administration 33.44 16.39 21 45243 203616 110340419
Bradycardia 33.37 16.39 11 45253 155506 110388529
Gastrooesophageal reflux disease 33.27 16.39 16 45248 179960 110364075
Amyloidosis 33.24 16.39 19 45245 3162 110540873
Purpura 32.76 16.39 45 45219 24343 110519692
Therapeutic response decreased 32.43 16.39 100 45164 96399 110447636
Pain 31.82 16.39 558 44706 954397 109589638
Hypertensive cardiomyopathy 31.54 16.39 10 45254 380 110543655
Erythema 31.47 16.39 44 45220 291403 110252632
Sepsis 31.14 16.39 235 45029 327111 110216924
Blood glucose increased 30.94 16.39 8 45256 132488 110411547
Helicobacter infection 30.92 16.39 18 45246 181859 110362176
Hypokalaemia 30.77 16.39 152 45112 182296 110361739
Deep vein thrombosis 30.69 16.39 126 45138 139761 110404274
Joint injury 30.50 16.39 57 45207 39937 110504098
Dry skin 30.48 16.39 4 45260 107649 110436386
Back disorder 30.23 16.39 40 45224 20882 110523153
Hepatosplenomegaly 30.13 16.39 24 45240 6895 110537140
Oral fungal infection 29.74 16.39 20 45244 4432 110539603
White blood cell count decreased 29.71 16.39 30 45234 229360 110314675
Inflammatory marker increased 29.62 16.39 33 45231 14436 110529599
Parvovirus infection 29.53 16.39 12 45252 939 110543096
Toothache 29.43 16.39 42 45222 23533 110520502
Haematochezia 28.92 16.39 6 45258 115518 110428517
Skin graft infection 28.70 16.39 7 45257 98 110543937
Mucosal inflammation 28.64 16.39 3 45261 96138 110447897
Fibromyalgia 28.55 16.39 142 45122 170767 110373268
Irritable bowel syndrome 28.28 16.39 16 45248 164199 110379836
Duodenal ulcer perforation 28.26 16.39 19 45245 177681 110366354
Laryngeal stenosis 28.18 16.39 13 45251 1385 110542650
Vision blurred 27.91 16.39 9 45255 129013 110415022
Dysphagia 27.87 16.39 14 45250 153586 110390449
Lethargy 27.67 16.39 3 45261 93573 110450462
Bronchitis 27.47 16.39 15 45249 157017 110387018
Renal failure 27.06 16.39 172 45092 226402 110317633
Product dose omission issue 27.03 16.39 57 45207 321725 110222310
Chills 26.95 16.39 23 45241 190557 110353478
Skin fissures 26.83 16.39 41 45223 24417 110519618
Muscle injury 26.83 16.39 12 45252 140795 110403240
Medical device site discomfort 26.76 16.39 8 45256 249 110543786
Anaemia 26.75 16.39 124 45140 546962 109997073
Myalgia 26.67 16.39 31 45233 222350 110321685
Product use in unapproved indication 26.58 16.39 290 44974 447087 110096948
Hypofibrinogenaemia 26.26 16.39 15 45249 2492 110541543
Agitation 26.07 16.39 7 45257 113044 110430991
Depressed level of consciousness 25.80 16.39 7 45257 112271 110431764
Testicular seminoma (pure) 25.27 16.39 7 45257 165 110543870
Borrelia infection 25.20 16.39 8 45256 305 110543730
Chronic obstructive pulmonary disease 24.72 16.39 7 45257 109151 110434884
Gastrointestinal haemorrhage 24.62 16.39 19 45245 165499 110378536
Suicide attempt 24.61 16.39 6 45258 103388 110440647
Injury 24.33 16.39 22 45242 177243 110366792
Tumour necrosis factor receptor-associated periodic syndrome 24.27 16.39 6 45258 89 110543946
Hyperplasia 24.15 16.39 12 45252 1506 110542529
Diaphragm muscle weakness 24.09 16.39 7 45257 197 110543838
Urinary tract infection 24.03 16.39 62 45202 326220 110217815
Acute kidney injury 23.95 16.39 157 45107 635273 109908762
Opportunistic infection 23.87 16.39 16 45248 3527 110540508
Central nervous system lymphoma 23.57 16.39 15 45249 3029 110541006
Muckle-Wells syndrome 23.54 16.39 4 45260 6 110544029
Fluid retention 23.39 16.39 5 45259 94302 110449733
Oxygen saturation decreased 23.37 16.39 18 45246 156964 110387071
Bronchopulmonary aspergillosis 23.32 16.39 43 45221 29820 110514215
Acne cystic 23.25 16.39 10 45254 902 110543133
Focal nodular hyperplasia 23.24 16.39 10 45254 903 110543132
Rectal haemorrhage 23.16 16.39 10 45254 119823 110424212
Incorrect dose administered 22.82 16.39 7 45257 103634 110440401
Rhinorrhoea 22.49 16.39 7 45257 102659 110441376
Splenic abscess 22.37 16.39 10 45254 990 110543045
Breast ulceration 22.25 16.39 7 45257 259 110543776
Epistaxis 22.02 16.39 13 45251 130359 110413676
Demyelination 21.92 16.39 23 45241 9406 110534629
Visual impairment 21.88 16.39 14 45250 134414 110409621
Wound 21.88 16.39 39 45225 234398 110309637
Sleep disorder due to general medical condition, insomnia type 21.76 16.39 8 45256 105635 110438400
Symptom recurrence 21.74 16.39 17 45247 4755 110539280
Impaired gastric emptying 21.73 16.39 27 45237 13248 110530787
Acute myocardial infarction 21.71 16.39 4 45260 83773 110460262
Lip dry 21.61 16.39 7 45257 100076 110443959
Pyrexia 21.58 16.39 500 44764 897765 109646270
Epstein-Barr viraemia 21.36 16.39 15 45249 3564 110540471
Cutaneous amyloidosis 21.21 16.39 5 45259 60 110543975
Tooth disorder 21.20 16.39 41 45223 29468 110514567
Skin exfoliation 21.03 16.39 5 45259 87646 110456389
Nasal congestion 21.00 16.39 7 45257 98275 110445760
Hodgkin's disease 20.94 16.39 9 45255 811 110543224
Varicella 20.71 16.39 15 45249 3740 110540295
Infusion related reaction 20.69 16.39 83 45181 381079 110162956
Spondyloarthropathy 20.60 16.39 11 45253 1603 110542432
Chronic infantile neurological cutaneous and articular syndrome 20.41 16.39 3 45261 0 110544035
Multiple-drug resistance 20.20 16.39 26 45238 13209 110530826
Mouth ulceration 20.16 16.39 54 45210 48084 110495951
Skin striae 19.97 16.39 12 45252 2189 110541846
Aspartate aminotransferase increased 19.49 16.39 22 45242 159914 110384121
Abdominal distension 19.33 16.39 26 45238 175077 110368958
Bacteraemia 19.23 16.39 49 45215 42341 110501694
Chest pain 19.16 16.39 84 45180 376291 110167744
Wrong technique in product usage process 19.05 16.39 6 45258 87342 110456693
Hyperlipidaemia 19.00 16.39 44 45220 35804 110508231
Mental status changes 18.95 16.39 4 45260 76118 110467917
Nasopharyngitis 18.90 16.39 90 45174 394271 110149764
Drug dependence 18.86 16.39 54 45210 49966 110494069
Embolism 18.85 16.39 28 45236 16261 110527774
Seizure 18.72 16.39 39 45225 221146 110322889
Prescribed underdose 18.70 16.39 64 45200 65110 110478925
Alanine aminotransferase increased 18.60 16.39 29 45235 183744 110360291
Bacterial tracheitis 18.51 16.39 5 45259 107 110543928
Chondrocalcinosis 18.48 16.39 11 45253 1974 110542061
Posterior reversible encephalopathy syndrome 18.43 16.39 42 45222 33819 110510216
Melaena 18.43 16.39 3 45261 68754 110475281
Bacterial sepsis 18.35 16.39 22 45242 10404 110533631
Solar urticaria 18.29 16.39 5 45259 112 110543923
Hospitalisation 18.03 16.39 19 45245 142474 110401561
Liver disorder 17.96 16.39 19 45245 142224 110401811
Viral infection 17.79 16.39 55 45209 53084 110490951
Haematuria 17.58 16.39 6 45258 82999 110461036
Seminoma 17.58 16.39 6 45258 288 110543747
Orthostatic hypotension 17.52 16.39 3 45261 66246 110477789
Periodontal inflammation 17.45 16.39 4 45260 42 110543993
Blood creatinine increased 17.45 16.39 30 45234 182859 110361176
Colitis ulcerative 17.44 16.39 5 45259 77358 110466677
Cystitis 17.44 16.39 3 45261 66033 110478002
International normalised ratio increased 17.16 16.39 7 45257 86765 110457270
Blood alkaline phosphatase increased 17.11 16.39 4 45260 70931 110473104
Soft tissue swelling 17.09 16.39 10 45254 1739 110542296
Chronic kidney disease 17.07 16.39 5 45259 76286 110467749
Spinal fracture 16.94 16.39 32 45232 22601 110521434
Joint range of motion decreased 16.86 16.39 15 45249 121817 110422218
Transient ischaemic attack 16.69 16.39 3 45261 63979 110480056
Hypertransaminasaemia 16.57 16.39 33 45231 24222 110519813
Hand deformity 16.53 16.39 149 45115 218357 110325678

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC L04AC03 ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
Interleukin inhibitors
FDA MoA N0000175709 Interleukin 1 Receptor Antagonists
FDA EPC N0000175710 Interleukin-1 Receptor Antagonist
MeSH PA D018501 Antirheumatic Agents
CHEBI has role CHEBI:22587 antiviral agent
CHEBI has role CHEBI:33281 antimicrobial agent
CHEBI has role CHEBI:35441 antiinfective agent
CHEBI has role CHEBI:35480 analgesic
CHEBI has role CHEBI:35526 hypoglycemic agent
CHEBI has role CHEBI:35554 cardiovascular drug
CHEBI has role CHEBI:35610 antineoplastic agent
CHEBI has role CHEBI:35674 antihypertensive agent
CHEBI has role CHEBI:35705 immunosuppressive agent
CHEBI has role CHEBI:35842 antirheumatic drug
CHEBI has role CHEBI:35845 gout suppressant
CHEBI has role CHEBI:50177 dermatologic drug
CHEBI has role CHEBI:63726 neuroprotective agent
CHEBI has role CHEBI:64946 anti-HIV agent
CHEBI has role CHEBI:65023 anti-asthmatic agent
CHEBI has role CHEBI:66981 ophthalmology drug
CHEBI has role CHEBI:76916 hyperglycemic agent
CHEBI has role CHEBI:149553 anticoronaviral agent

Related Drugs by ATC class:

L04AC Interleukin inhibitors 18 drugs

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Familial Mediterranean fever indication 12579009 DOID:2987
Rheumatoid arthritis indication 69896004 DOID:7148
Chronic infantile neurological, cutaneous and articular syndrome indication 239826001
Still's disease indication 239920006 DOID:14256
Cryopyrin associated periodic syndrome indication 430079001
COVID19 pneumonia requiring supplemental oxygen indication 882785000000000000




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Interleukin-1 receptor, type I Membrane receptor ANTAGONIST Kd 7.82 IUPHAR DRUG LABEL

External reference:

IDSource
D02934 KEGG_DRUG
4021281 VUID
N0000179382 NUI
4021281 VANDF
CHEBI:231683 CHEBI
CHEMBL1201570 ChEMBL_ID
6972 IUPHAR_LIGAND_ID
DB00026 DRUGBANK_ID
352734 RXNORM
16200 MMSL
42416 MMSL
d04775 MMSL
009431 NDDF
009432 NDDF
385549000 SNOMEDCT_US
395279009 SNOMEDCT_US
C0245109 UMLSCUI
D053590 MESH_DESCRIPTOR_UI
7137 INN_ID
9013DUQ28K UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Kineret HUMAN PRESCRIPTION DRUG LABEL 1 66658-234 INJECTION, SOLUTION 100 mg SUBCUTANEOUS BLA 33 sections
Kineret HUMAN PRESCRIPTION DRUG LABEL 1 66658-234 INJECTION, SOLUTION 100 mg SUBCUTANEOUS BLA 33 sections